Impact of the COVID-19 pandemic on the utilization and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time series analysis.

Antimicrobial resistance COVID-19 Scotland antibiotic utilization primary care quality indicator segmented regression

Journal

Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284

Informations de publication

Date de publication:
05 Jun 2024
Historique:
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: aheadofprint

Résumé

Inappropriate use of antibiotics is expected to increase during the COVID-19 pandemic but there is limited data on COVID-19's long-term impact. We assessed the impact of COVID-19 on the quantity and quality of antibiotic use in Scotland. A segmented interrupted time series was applied to monthly dispensed antibiotics using Prescription Cost analysis data from March/2019 to March/2023. Antibiotics use was quantified using number of items dispensed/1000 inhabitants (TID) and defined daily dose/1000 inhabitants/day (DID). Quality of antibiotic use was assessed using key quality indicators including the WHO AWaRe classification proportion of broad-spectrum and 4C-antibiotics. Overall, for all antibiotics, there was a non-significant increase in TID and DID before the first lockdown (March/2020) (β Neither the utilization nor the quality of total antibiotic use appeared to have been significantly affected by COVID-19.

Sections du résumé

BACKGROUND UNASSIGNED
Inappropriate use of antibiotics is expected to increase during the COVID-19 pandemic but there is limited data on COVID-19's long-term impact. We assessed the impact of COVID-19 on the quantity and quality of antibiotic use in Scotland.
RESEARCH DESIGN AND METHODS UNASSIGNED
A segmented interrupted time series was applied to monthly dispensed antibiotics using Prescription Cost analysis data from March/2019 to March/2023. Antibiotics use was quantified using number of items dispensed/1000 inhabitants (TID) and defined daily dose/1000 inhabitants/day (DID). Quality of antibiotic use was assessed using key quality indicators including the WHO AWaRe classification proportion of broad-spectrum and 4C-antibiotics.
RESULTS UNASSIGNED
Overall, for all antibiotics, there was a non-significant increase in TID and DID before the first lockdown (March/2020) (β
CONCLUSIONS UNASSIGNED
Neither the utilization nor the quality of total antibiotic use appeared to have been significantly affected by COVID-19.

Identifiants

pubmed: 38836493
doi: 10.1080/14787210.2024.2363485
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Hayam Al Balushi (H)

Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK.
Directorate General of Pharmaceutical Affairs and Drug Control, Ministry of Health, Oman.
Department of Clinical Pharmacy, College of Pharmacy, Hawler Medical University, Kurdistan Regional Governorate, Erbil, Iraq.

Amanj Kurdi (A)

College of Pharmacy, Al-Kitab University, Kirkuk, Iraq.
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Najla Almutairi (N)

Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK.

Kirmanj Ismail Baker (KI)

Department of Surgery, College of Medicine, University of Kirkuk, Kirkuk, Iraq.

Karwan Amen (K)

Department of Nursing, College of Nursing, Hawler Medical University, Erbil, Iraq.

Hardee Karwi (H)

Azadi Teaching Hospital, Kirkuk Health Directorate, Ministry of Health, Kirkuk, Iraq.

Ra Seaton (R)

Queen Elizabeth University Hospital, Glasgow, UK.

Brian Godman (B)

School of Medicine, University of Glasgow, Glasgow, UK.
Centre of Medical and Bio allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.

Classifications MeSH